54 results
Page 2 of 3
8-K
EX-99.2
eo8kdfvan8864y
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
8-K
EX-99.1
g09 7fof3v3y
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
EX-99.1
kacngn37ne7 08g3
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-1.1
s6u5sykibt5nu9xyt1j
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-99.1
cfa owgo7omgebm6o6tq
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
8-K
EX-99.2
6y90tzf
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
8-K
EX-1.1
uggxze9skymbvr6j
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
8-K
EX-99.1
ydtik
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
S-3
EX-1.2
uzyhkhmya
13 Aug 19
Shelf registration
4:36pm
DEF 14A
xnuqpliwy 80gc0
29 Apr 19
Definitive proxy
12:00am
424B4
1vqn6od m7z5yj
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
EX-10.1
6hm7yu9f
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-10.8
la2ebi
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-1.1
m8b1ta v4vuc02j07
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
mct3meb
9 Jul 18
IPO registration (amended)
6:10am
S-1
EX-10.1
6ty8s788gwn7xfnd6hz
22 Jun 18
IPO registration
4:07pm
S-1
EX-10.6
mvja8s
22 Jun 18
IPO registration
4:07pm